Valproic acid suppresses interleukin-1β-induced microsomal prostaglandin E2 Synthase-1 expression in chondrocytes

被引:0
|
作者
N Zayed
N Chabane
J Martel-Pelletier
J P Pelletier
N Duval
H Fahmi
机构
[1] Notre-Dame Hospital,Osteoarthritis Research Unit, Research Centre of the University of Montreal Hospital Center (CR
[2] and Dept. of Medicine,CHUM)
[3] University of Montreal,undefined
关键词
PGE2; Valproic Acid; Histone Deacetylase; Transient Transfection; Chromatin Immunoprecipitation;
D O I
10.1186/1479-5876-8-S1-P60
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Interleukin-1β induces matrix metalloproteinase-1 expression in cultured human gingival fibroblasts:: role of cyclooxygenase-2 and prostaglandin E2
    Sakaki, H
    Matsumiya, T
    Kusumi, A
    Imaizumi, T
    Satoh, H
    Yoshida, H
    Satoh, K
    Kimura, H
    ORAL DISEASES, 2004, 10 (02) : 87 - 93
  • [32] Epigenetic control of microsomal prostaglandin E synthase-1 by HDAC-mediated recruitment of p300
    Fork, Christian
    Vasconez, Andrea E.
    Janetzko, Patrick
    Angioni, Carlo
    Schreiber, Yannick
    Ferreiros, Nerea
    Geisslinger, Gerd
    Leisegang, Matthias S.
    Steinhilber, Dieter
    Brandes, Ralf P.
    JOURNAL OF LIPID RESEARCH, 2017, 58 (02) : 386 - 392
  • [33] Toward the Discovery of New Agents Able to Inhibit the Expression of Microsomal Prostaglandin E Synthase-1 Enzyme as Promising Tools in Drug Development
    De Simone, Rosa
    Andres, Rosa M.
    Aquino, Maurizio
    Bruno, Ines
    Guerrero, Maria D.
    Terencio, Maria C.
    Paya, Miguel
    Riccio, Raffaele
    CHEMICAL BIOLOGY & DRUG DESIGN, 2010, 76 (01) : 17 - 24
  • [34] Insights on Microsomal Prostaglandin E2 Synthase 1 (mPGES-1) Inhibitors using Molecular Dynamics and MM/PBSA Calculations
    dos Santos Nascimento, Igor Jose
    de Aquino, Thiago Mendonca
    da Silva Junior, Edeildo Ferreira
    de Moura, Ricardo Olimpio
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (06) : 1033 - 1047
  • [35] c-Fos immunoreactivity induced by intraperitoneal LPS administration is reduced in the brain of mice lacking the microsomal prostaglandin E synthase-1 (mPGES-1)
    Dallaporta, M.
    Pecchi, E.
    Jacques, C.
    Berenbaum, F.
    Jean, A.
    Thirion, S.
    Troadec, J. D.
    BRAIN BEHAVIOR AND IMMUNITY, 2007, 21 (08) : 1109 - 1121
  • [36] Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase
    Ergul, Azize Gizem
    Maz, Tugce Gur
    Kretzer, Christian
    Olgac, Abdurrahman
    Jordan, Paul M.
    Caliskan, Burcu
    Werz, Oliver
    Banoglu, Erden
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 231
  • [37] Structural and functional characterization of human microsomal prostaglandin E synthase-1 by computational modeling and site-directed mutagenesis
    Huang, XQ
    Yan, WL
    Gao, DQ
    Tong, M
    Tai, HH
    Zhan, CG
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (10) : 3553 - 3562
  • [38] Discovery and optimization of pyridyl-cycloalkyl-carboxylic acids as inhibitors of microsomal prostaglandin E synthase-1 for the treatment of endometriosis
    Koppitz, Marcus
    Braeuer, Nico
    Ter Laak, Antonius
    Irlbacher, Horst
    Rotgeri, Andrea
    Coelho, Anne-Marie
    Walter, Daryl
    Steinmeyer, Andreas
    Zollner, Thomas M.
    Peters, Michaele
    Nagel, Jens
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (18) : 2700 - 2705
  • [39] Microsomal prostaglandin E synthase-1, ephrins, and ephrin kinases as suspected therapeutic targets in arthritis - Exposed by "criminal profiling"
    Romanovsky, Andrej A.
    Ivanov, Andrei I.
    Petersen, Scott R.
    BASIC AND CLINICAL ASPECTS OF NEUROENDOCRINE IMMUNOLOGY IN RHEUMATIC DISEASES, 2006, 1069 : 183 - 194
  • [40] Effects of microsomal prostaglandin E synthase-1 inhibition on resistance artery tone in patients with end stage kidney disease
    Steinmetz-Spah, Julia
    Arefin, Samsul
    Larsson, Karin
    Jahan, Jabin
    Mudrovcic, Neja
    Wennberg, Lars
    Stenvinkel, Peter
    Korotkova, Marina
    Kublickiene, Karolina
    Jakobsson, Per-Johan
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (07) : 1433 - 1449